 William Silvers
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypersensitivity | 12 | 2024 | 252 | 2.140 |
Why?
| | Holocaust | 3 | 2021 | 16 | 1.420 |
Why?
| | Cannabis | 9 | 2024 | 509 | 1.190 |
Why?
| | Integrative Medicine | 2 | 2020 | 17 | 1.160 |
Why?
| | Allergists | 3 | 2024 | 13 | 1.010 |
Why?
| | Rhinitis, Allergic | 2 | 2018 | 42 | 0.980 |
Why?
| | Allergens | 4 | 2022 | 384 | 0.870 |
Why?
| | Asthma | 7 | 2024 | 1768 | 0.830 |
Why?
| | Asthma, Exercise-Induced | 4 | 2018 | 14 | 0.780 |
Why?
| | Bioethics | 1 | 2021 | 25 | 0.650 |
Why?
| | Students, Health Occupations | 1 | 2021 | 37 | 0.640 |
Why?
| | Complementary Therapies | 3 | 2020 | 94 | 0.600 |
Why?
| | Medicine | 1 | 2021 | 125 | 0.580 |
Why?
| | Sports | 2 | 2018 | 211 | 0.500 |
Why?
| | Conjunctivitis | 1 | 2016 | 30 | 0.460 |
Why?
| | Interviews as Topic | 1 | 2018 | 901 | 0.410 |
Why?
| | Exercise | 3 | 2018 | 2201 | 0.380 |
Why?
| | Skin | 1 | 2017 | 758 | 0.370 |
Why?
| | Occupational Exposure | 3 | 2020 | 354 | 0.350 |
Why?
| | Surveys and Questionnaires | 7 | 2024 | 6053 | 0.250 |
Why?
| | Gastric Mucosa | 1 | 2006 | 52 | 0.230 |
Why?
| | Vocal Cords | 1 | 2006 | 26 | 0.230 |
Why?
| | Esophageal Diseases | 1 | 2006 | 30 | 0.230 |
Why?
| | Laryngeal Diseases | 1 | 2006 | 31 | 0.230 |
Why?
| | Bronchoconstriction | 2 | 2016 | 29 | 0.230 |
Why?
| | Athletes | 2 | 2019 | 419 | 0.220 |
Why?
| | Cough | 1 | 2006 | 124 | 0.220 |
Why?
| | Rhinitis | 1 | 2006 | 171 | 0.200 |
Why?
| | Prevalence | 4 | 2019 | 2836 | 0.200 |
Why?
| | Physicians | 2 | 2022 | 940 | 0.190 |
Why?
| | History, 20th Century | 2 | 2021 | 325 | 0.180 |
Why?
| | Humans | 25 | 2024 | 144957 | 0.180 |
Why?
| | Antigens, Plant | 2 | 2022 | 55 | 0.170 |
Why?
| | Humanities | 1 | 2021 | 8 | 0.170 |
Why?
| | Curriculum | 2 | 2021 | 1060 | 0.170 |
Why?
| | Health Occupations | 1 | 2021 | 36 | 0.160 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 164 | 0.150 |
Why?
| | Teaching | 1 | 2021 | 236 | 0.140 |
Why?
| | Marijuana Smoking | 2 | 2021 | 250 | 0.140 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1416 | 0.140 |
Why?
| | Medication Reconciliation | 1 | 2018 | 31 | 0.130 |
Why?
| | Cross Reactions | 1 | 2017 | 130 | 0.130 |
Why?
| | Medical History Taking | 1 | 2018 | 117 | 0.130 |
Why?
| | Schools | 1 | 2021 | 453 | 0.130 |
Why?
| | Medical Marijuana | 1 | 2019 | 123 | 0.130 |
Why?
| | Respiratory System | 1 | 2018 | 149 | 0.120 |
Why?
| | Marijuana Use | 1 | 2019 | 213 | 0.110 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 241 | 0.110 |
Why?
| | Administration, Oral | 1 | 2017 | 848 | 0.110 |
Why?
| | Biological Products | 1 | 2018 | 252 | 0.110 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 361 | 0.100 |
Why?
| | Bronchial Diseases | 1 | 2014 | 38 | 0.100 |
Why?
| | Schools, Medical | 1 | 2015 | 157 | 0.100 |
Why?
| | Physician's Role | 1 | 2015 | 220 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2017 | 590 | 0.100 |
Why?
| | Comorbidity | 1 | 2018 | 1660 | 0.090 |
Why?
| | Pancreas | 1 | 2015 | 342 | 0.090 |
Why?
| | Zinc | 1 | 2015 | 295 | 0.090 |
Why?
| | Sex Factors | 1 | 2018 | 2114 | 0.090 |
Why?
| | Patient Preference | 1 | 2014 | 225 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1268 | 0.080 |
Why?
| | Precision Medicine | 1 | 2014 | 458 | 0.080 |
Why?
| | Rhinitis, Allergic, Perennial | 1 | 2009 | 20 | 0.070 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2009 | 25 | 0.070 |
Why?
| | Holistic Health | 1 | 2009 | 16 | 0.070 |
Why?
| | United States | 5 | 2020 | 15988 | 0.070 |
Why?
| | Colorado | 1 | 2017 | 4564 | 0.060 |
Why?
| | Male | 8 | 2024 | 72406 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 732 | 0.060 |
Why?
| | 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2006 | 1 | 0.060 |
Why?
| | Lansoprazole | 1 | 2006 | 2 | 0.060 |
Why?
| | Omeprazole | 1 | 2006 | 8 | 0.060 |
Why?
| | Fluticasone | 1 | 2006 | 53 | 0.060 |
Why?
| | Androstadienes | 1 | 2006 | 76 | 0.060 |
Why?
| | Anti-Allergic Agents | 1 | 2006 | 40 | 0.060 |
Why?
| | Middle Aged | 6 | 2024 | 35928 | 0.060 |
Why?
| | Health Education | 1 | 2009 | 358 | 0.060 |
Why?
| | Adult | 7 | 2024 | 40506 | 0.060 |
Why?
| | Quality Improvement | 1 | 2014 | 1291 | 0.060 |
Why?
| | Demography | 1 | 2006 | 288 | 0.060 |
Why?
| | Female | 7 | 2024 | 78376 | 0.050 |
Why?
| | Proton Pump Inhibitors | 1 | 2006 | 109 | 0.050 |
Why?
| | Insulin | 1 | 2015 | 2507 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2006 | 547 | 0.050 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2006 | 237 | 0.050 |
Why?
| | Quality of Life | 2 | 2021 | 3192 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2884 | 0.050 |
Why?
| | Knowledge | 1 | 2022 | 57 | 0.040 |
Why?
| | Skin Tests | 1 | 2022 | 94 | 0.040 |
Why?
| | Industry | 1 | 2020 | 43 | 0.040 |
Why?
| | Immunoglobulin E | 1 | 2022 | 315 | 0.040 |
Why?
| | Allergy and Immunology | 1 | 2020 | 42 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 261 | 0.040 |
Why?
| | Cannabidiol | 1 | 2021 | 136 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 231 | 0.040 |
Why?
| | Cannabinoids | 1 | 2021 | 182 | 0.030 |
Why?
| | Animals | 3 | 2018 | 38109 | 0.030 |
Why?
| | Dronabinol | 1 | 2021 | 247 | 0.030 |
Why?
| | Risk | 1 | 2020 | 911 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 160 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2018 | 148 | 0.030 |
Why?
| | Immunity, Cellular | 1 | 2018 | 272 | 0.030 |
Why?
| | Health Personnel | 1 | 2022 | 748 | 0.030 |
Why?
| | Needles | 1 | 2015 | 62 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1253 | 0.030 |
Why?
| | Fluoroscopy | 1 | 2015 | 176 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 208 | 0.030 |
Why?
| | Portal Vein | 1 | 2015 | 114 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1173 | 0.030 |
Why?
| | Canada | 1 | 2015 | 428 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2018 | 735 | 0.020 |
Why?
| | Spleen | 1 | 2015 | 508 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1695 | 0.020 |
Why?
| | Immunotherapy | 1 | 2018 | 657 | 0.020 |
Why?
| | Swine | 1 | 2015 | 833 | 0.020 |
Why?
| | Education, Medical, Undergraduate | 1 | 2015 | 207 | 0.020 |
Why?
| | Contrast Media | 1 | 2015 | 488 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2882 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3335 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 770 | 0.020 |
Why?
| | Bronchial Spasm | 1 | 2010 | 2 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 781 | 0.020 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 388 | 0.020 |
Why?
| | Diet Therapy | 1 | 2010 | 37 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2018 | 1524 | 0.020 |
Why?
| | Drug Therapy | 1 | 2010 | 80 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3550 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1990 | 0.020 |
Why?
| | Academies and Institutes | 1 | 2009 | 60 | 0.020 |
Why?
| | Health Resources | 1 | 2009 | 130 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5997 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1495 | 0.020 |
Why?
| | Data Collection | 1 | 2009 | 635 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3415 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2738 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14126 | 0.010 |
Why?
| | Health Behavior | 1 | 2009 | 786 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1813 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22453 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2009 | 2947 | 0.010 |
Why?
| | Mice | 1 | 2018 | 18365 | 0.010 |
Why?
| | Aged | 1 | 2020 | 25947 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 5417 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 11695 | 0.010 |
Why?
|
|
Silvers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|